Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director | June 01, 2026 | June 03, 2026 |
| Concentrix CorpCNXC · Entity 4519 | Director | March 25, 2026 | March 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,716 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Exercise / conversion · Acquired 668 · Balance 4,716 |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-06-01 | Direct | 5,772 |
Reported balance
After 2026-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-01 · Grant · Acquired 5,772 · Balance 5,772 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2035-06-02 | Direct | 0 |
Reported balance
After 2026-06-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-02 · Exercise / conversion · Disposed 668 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
Concentrix Corp
Report date March 25, 2026 · Filed March 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,704 |
Reported balance
After 2026-03-25 transaction · row 1
1 source rowRow 1 · 2026-03-25 · Grant · Acquired 7,701 · Balance 17,704 F1: Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 3, 2026 20:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000073 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 668 shares Expires 2035-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 668 | $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000073 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:18 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 5,772 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000073 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,772 Underlying: Common Stock · 5,772 shares Expires 2036-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 09:35 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 7,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-26-000110 · wk-form4_1774618526.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,704 F1 · shares: Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:34 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016760 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 479 shares Expires 2034-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:34 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 479 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016760 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:34 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016760 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668 Underlying: Common Stock · 668 shares Expires 2035-06-02 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:34 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 8,061 | $0.00 Strike: $55.38 | $0.00 |
DisclosureSEC source: 0001127602-25-016760 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,061 Underlying: Common Stock · 8,061 shares Expires 2035-06-02 F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 16:33 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 3,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-25-000096 · wk-form4_1743107583.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,003 F1 · kind: Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2026 Annual Meeting of Stockholders. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:06 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:06 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 18:00 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 2,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-24-000088 · wk-form4_1711144819.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,130 F1 · kind: Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:25 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-23-000060 · wf-form4_167995229974417.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,350 F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 17:17 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-22-000058 · wf-form4_164815665770200.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,868 F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2023 Annual Meeting of Stockholders. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 17:58 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000084 · wf-form4_161912866646133.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118 F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2022 Annual Meeting of Stockholders. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 17:22 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 306 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-21-000027 · wf-form4_161135412222630.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306 F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests in full on the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| December 02, 2020 Filed Dec 3, 2020 21:19 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 599 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030417 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 599 shares Expires 2029-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting on December 2, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting. Read SEC document |
| December 02, 2020 Filed Dec 3, 2020 21:19 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 599 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030417 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:30 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018659 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:30 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018659 · form4.xml · derivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 22:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 987 | $0.00 Strike: $112.55 | $0.00 |
DisclosureSEC source: 0001127602-19-034171 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987 Underlying: Common Stock · 987 shares Expires 2029-12-02 F2 · derivative.exercise_date: The incentive stock options ("Options") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan with the Options generally vesting on December 2, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 22:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 599 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034171 · form4.xml · derivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599 Underlying: Common Stock · 599 shares Expires 2029-12-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting on December 2, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.